Obesity drugs strive for US approval

被引：0

|

作者：

Turley, Andrew

机构：

来源：

CHEMISTRY WORLD | 2010年 / 7卷 / 10期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：12 / 12

页数：1

相关论文

共 50 条

[1] Drugs - Abortion pill wins approval in the US
不详
[J]. CHEMISTRY & INDUSTRY, 2000, (20) : 662 - 662
[2] Approval and Coverage of Cancer Drugs in England, Canada, and the US
Prasad, Vinay
Kim, Myung S.
[J]. JAMA INTERNAL MEDICINE, 2021, 181 (04) : 509 - 510
[3] EU and US harmonise orphan drugs approval procedures
不详
[J]. EJHP PRACTICE, 2008, 14 (02): : 14 - 14
[4] THE NAASO POSITION PAPER ON APPROVAL AND USE OF DRUGS TO TREAT OBESITY
PISUNYER, X
[J]. OBESITY RESEARCH, 1995, 3 (05): : 471 - 472
[5] US FDA advisors recommend the approval of obesity drug Qnexa®
Dowdall, Michael
[J]. CLINICAL LIPIDOLOGY, 2012, 7 (02) : 133 - 134
[6] Regulatory approval pathways for anticancer drugs in Japan, the EU and the US
Nagai, Sumimasa
Ozawa, Keiya
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (01) : 73 - 84
[7] Food and Drug Administration approval process for ophthalmic drugs in the US
Lloyd, Rhea
Harris, Jennifer
Wadhwa, Sonal
Chambers, Wiley
[J]. CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (03) : 190 - 194
[8] US FDA's safety monitoring of drugs with expedited approval
Furlow, Bryant
[J]. LANCET ONCOLOGY, 2016, 17 (03): : 281 - 281
[9] Clamp down on Rx drugs without US FDA approval
[J]. Reactions Weekly, 2006, 1106 (1) : 3 - 3
[10] Regulatory approval pathways for anticancer drugs in Japan, the EU and the US
Sumimasa Nagai
Keiya Ozawa
[J]. International Journal of Hematology, 2016, 104 : 73 - 84

← 1 2 3 4 5 →